Mesenchymal Stem Cell Culture Medium Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current mesenchymal stem cell culture media are costly and inefficient, limiting the economic viability and proliferation capabilities of stem cell therapy products.
Innovation Solution
A medium composition combining DMEM, α-MEM, IMDM, F12, and DMEM/F12 with Defined Keratinocyte-SFM, L-ascorbic acid 2-phosphate, fetal bovine serum, basic fibroblast growth factors, insulin, N-acetyl-L-cysteine, and hydrocortisone, which reduces production costs while maintaining high proliferation and differentiation abilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If expensive optimized stem cell culture medium is used, then stem cell proliferation ability and morphology retention are improved, but production cost increases
Solution Approach 1:
The culture medium is segmented into multiple components (DMEM, α-MEM, IMDM, F12, DMEM/F12, Defined Keratinocyte-SFM) with specific mixing ratios. This segmentation allows optimization of individual medium components while controlling overall cost, rather than using a single expensive proprietary medium formulation.
Solution Approach 2:
The invention changes the parameters of the culture medium by specifying precise mixing ratios of different base media (DMEM:α-MEM:IMDM:F12:DMEM/F12:Defined Keratinocyte-SFM = 5:3:2:1.5:1.5:1) and component concentrations (L-ascorbic acid 2-phosphate: 0.05-1mM, fetal bovine serum: 2-20%, basic fibroblast growth factor: 10-1ng/ml, insulin: 0.1-100μg/ml, N-acetyl-L-cysteine: 0.2-20mM, calcium chloride: 0.01-1mM, hydrocortisone: 5ng/ml-1μg/ml). This parameter optimization maintains stem cell proliferation ability while reducing production cost compared to proprietary media.
2Ease of manufacture
If commonly used quasi-completed medium is used, then production cost is reduced, but stem cell culture efficiency decreases
Solution Approach 1:
The invention creates a composite culture medium by combining multiple quasi-completed media (DMEM, α-MEM, IMDM, F12, DMEM/F12) with Defined Keratinocyte-SFM in specific ratios. This composite approach leverages the strengths of each individual medium while achieving cost reduction, producing a medium that is both economical and highly effective for stem cell culture.
3Productivity
If high concentration of growth factors and supplements is used, then cell proliferation ability is enhanced, but medium cost increases
Solution Approach 1:
The invention optimizes the concentration parameters of expensive growth factors and supplements to achieve cost-effective formulations. By specifying precise concentration ranges (basic fibroblast growth factor: 10-1ng/ml, insulin: 0.1-100μg/ml) and combining multiple media components, the invention maintains high cell proliferation ability while reducing overall medium cost through efficient use of expensive ingredients.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a medium composition for culturing stem cells and, more specifically, to a medium composition, containing a base medium mixed with various semi-complete media (DMEM, α-MEM, IMDM, F12, and DMEM/F12), L-ascrobic acid 2-phosphoric acid, bovine fatal serum, basic fibroblast growth factor (b-FGF), insulin, N-acetyl-L-cysteine, chloride calcium, and hydrocortisone, for culturing mesenchymal stem cells. According to the present invention, the differentiation ability and proliferation ability of the mesenchymal stem cells can be improved, and the mesenchymal stem cells can be cultured at a lower price compared with an existing culturing method, and thus a cell therapeutic agent using mesenchymal stem cells can be more economically produced.